Aurobindo Pharma Limited — Others, 13-12-2024: Cessation

Mrs. Savita Mahajan will retire as an Independent Director of Aurobindo Pharma on December 15, 2024, upon completing her second term. She will also step down from various Board Committees. This transition aligns with the company’s compliance with regulatory requirements. The change maintains board integrity and governance.

Investors may view this update as a neutral impact, highlighting ongoing compliance and governance standards while noting potential adjustments in board dynamics.